PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"PI3K/AKT/mTOR Inhibitors for Advanced or Recurrent Endometrial Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438805/1/Protease_activity_as_a_prognostic_factor_for_wound_healing_in_venous_leg_ulcers_New. Accessed 24 April 2024.
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438805/1/Protease_activity_as_a_prognostic_factor_for_wound_healing_in_venous_leg_ulcers_New. Accessed April 24, 2024.
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438805/1/Protease_activity_as_a_prognostic_factor_for_wound_healing_in_venous_leg_ulcers_New
PI3K/AKT/mTOR Inhibitors for Advanced or Recurrent Endometrial Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 April 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438805/1/Protease_activity_as_a_prognostic_factor_for_wound_healing_in_venous_leg_ulcers_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
ID - 438805
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438805/1/Protease_activity_as_a_prognostic_factor_for_wound_healing_in_venous_leg_ulcers_New
DB - Evidence Central
DP - Unbound Medicine
ER -